35 U.S.C. § 271(f)(1)
Life Technologies Corporation, et al. v. Promega Corporation14-1538
Whether the Federal Circuit erred in holding that supplying a single, commodity component of a multi-component invention from the United States is an infringing act under 35 U.S.C. § 271(f)(1), exposing the manufacturer to liability for all worldwide sales.
DECISIONDecided February 22, 2017 HOLDING
The supply of a single component of a multicomponent invention for manufacture abroad does not give rise to §271(f)(1) liability.
SOTOMAYOR, J., delivered the opinion of the Court, in which KENNEDY, GINSBURG, BREYER, and KAGAN, JJ., joined, and in which THOMAS and ALITO, JJ., joined as to all but Part II–C. ALITO, J., filed an opinion concurring in part and concurring in the judgment, in which THOMAS, J., joined. ROBERTS, C. J., took no part in the decision of the case.
ORAL ARGUMENTArgued December 6, 2016
CERTIORARI STAGEGranted June 27, 2016
United States Court of Appeals for the Federal Circuit
Decided December 15, 2014